Using Lentivirus to Create Anti-Cancer T Cells
Author Information
Author(s): Simmons Anthony, Whitehead Robert P, Kolokoltsov Andrey A, Davey Robert A
Primary Institution: University of Texas Medical Branch, Galveston, Texas, USA
Hypothesis
Can lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G efficiently transduce human peripheral blood lymphocytes to generate anti-cancer chimeric T cells?
Conclusion
The study demonstrated that a lentivirus/VSV pseudotyped virus can efficiently transduce a high proportion of human peripheral blood lymphocytes with chimeric T cell receptors against CEA, leading to significant therapeutic effects in a mouse model of colon cancer.
Supporting Evidence
- Lentivirus pseudotyping with VSV-G resulted in nearly 100% transduction efficiency of human PBLs.
- Transduced PBLs showed specific proliferation in response to CEA-expressing cells.
- CEA-specific T-bodies caused significant regression of colon tumors in a mouse model.
Takeaway
Scientists used a special virus to help immune cells recognize and fight cancer cells better, and it worked really well in mice with colon cancer.
Methodology
The study involved transducing human peripheral blood lymphocytes with a lentivirus vector carrying a chimeric T cell receptor and assessing their proliferation and therapeutic effects in a mouse model.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Human peripheral blood lymphocytes were used for the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website